期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Photodynamic therapy for arthritis: A promising therapeutic strategy
1
作者 liangyu mi Jinfang Gao +4 位作者 Ying Liu Na Zhang miaomiao Zhao Sheng Wang Ke Xu 《Rheumatology & Autoimmunity》 2023年第4期205-219,共15页
Photodynamic therapy(PDT)is a novel therapy that combines photosensitizers,light,and oxygen molecules to treat diseases such as joint lesions and microbial infections through photodynamic reactions.The photosensitizer... Photodynamic therapy(PDT)is a novel therapy that combines photosensitizers,light,and oxygen molecules to treat diseases such as joint lesions and microbial infections through photodynamic reactions.The photosensitizers are activated under specific wavelengths of laser radiation to generate reactive oxygen species,which alter the microenvironment of the diseased tissue,cause ischemia and target cell death,and thus effectively treat cancer.Now that there is growing evidence that nonlethal doses of PDT reduce inflammation and treat infections in multiple animal models of arthritis,PDT should be considered as a new option for the treatment of arthritis.This article presents a literature review of published original articles and review articles concerning photodynamic therapy and arthritis.We conducted a comprehensive literature search in PubMed,Web of Science and Google Scholar databases,excluding duplicated and irrelevant studies.In cases of duplicated research,we selected articles with higher impact factors for the review.In this review,we summarize the application and progress of PDT in the treatment of rheumatoid arthritis,osteoarthritis,psoriatic arthritis,and infectious arthritis,and clarify the advantages and limitations of PDT for arthritis.PDT offers therapeutic value for patients with inflammatory and infectious arthritis through promoting vascular occlusion,cell death,and antibacterial therapy. 展开更多
关键词 infectious arthritis OSTEOARTHRITIS photodynamic therapy psoriatic arthritis rheumatoid arthritis
原文传递
Natural killer cells in obstetric antiphospholipid syndrome
2
作者 Rongxiu Huo Qianyu Guo +7 位作者 Junping Hu Na Li Hechao Liu Zhaoliang Zhang liangyu mi Xinyue Peng Liyun Zhang Ke Xu 《Chinese Medical Journal》 SCIE CAS CSCD 2022年第7期790-792,共3页
Antiphospholipid syndrome(APS)is a systemic autoimmune disease characterized by thrombotic or obstetric events caused by persistent antiphospholipid antibodies(aPLs),namely lupus anticoagulant,anticardiolipin antibodi... Antiphospholipid syndrome(APS)is a systemic autoimmune disease characterized by thrombotic or obstetric events caused by persistent antiphospholipid antibodies(aPLs),namely lupus anticoagulant,anticardiolipin antibodies,or anti-β2 glycoprotein I(anti-β2GPI)antibodies.^([1])The main target antigen in APS isβ2GPI,through which aPL binds to the cell membrane and subsequently activates membrane receptors and down-stream signal transducers.This may activate natural killer(NK)cells,leading to obstetric complications. 展开更多
关键词 KILLER ANTIBODIES GLYCOPROTEIN
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部